PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer
Clinical trial NCT00216047 · TERMINATED
Trial details
- NCT number
- NCT00216047
- Sponsor
- Hoosier Cancer Research Network
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2006-08-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.